Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery

Por Cuker, Adam, Rauova, Lubica, Bolgiano, Douglas, Matthai, William H., Poncz, Mortimer, Konkle, Barbara A.
Publicado em 2014

PERSISTENCE OF LYMPHOCYTOTOXIC ANTIBODIES IN PATIENTS IN THE TRIAL TO REDUCE ALLOIMMUNIZATION TO PLATELETS: IMPLICATIONS FOR USING MODIFIED BLOOD PRODUCTS

Por Slichter, Sherrill J., Bolgiano, Douglas, Kao, Kuo-Jang, Kickler, Thomas S., McFarland, Janice, McCullough, Jeffrey, Woodson, Robert
Publicado em 2011

Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants

Por Jackman, Rachael P., Deng, Xutao, Bolgiano, Douglas, Lebedeva, Mila, Heitman, John W., Busch, Michael P., Slichter, Sherrill J., Norris, Philip J.
Publicado em 2013

Leukoreduction and UV treatment reduce both the magnitude and duration of the anti-HLA antibody response

Por Jackman, Rachael P., Deng, Xutao, Bolgiano, Douglas, Utter, Garth H., Schechterly, Cathy, Lebedeva, Mila, Operskalski, Eva, Luban, Naomi L., Alter, Harvey, Busch, Michael P., Slichter, Sherrill J., Norris, Philip J.
Publicado em 2013